Hall Render

MAY 9, 2023

Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023). Still, telemedicine providers should closely monitor for the DEA’s final rules, once they are issued.

COVID-19 40

COVID-19 Telemedicine Health Services Administration Public Health 40

Health Law Advisor

MARCH 7, 2023

The proposed rules are more restrictive than the DEA emergency waivers under which providers conducted telemedicine prescribing for the last three years, but are less restrictive in comparison to the pre-PHE regulations applicable to telemedicine prescribing of controlled substances under the federal Controlled Substances Act (“CSA”).

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

Bill of Health

NOVEMBER 15, 2023

The nation’s experience with COVID-19 demonstrated the need for increased telemedicine options for the treatment of substance use, especially in suburban and rural areas where health provider closures may severely limit access to care. Code § 1701 et seq.

Governance 167

Governance Public Health Telemedicine Medicaid 167

Healthcare IT Today

MAY 14, 2023

News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the public health emergency, through November 11.

Ransomware 74

Ransomware Hospitals COVID-19 Health Services Administration 74